Phenytoin in topical formulations augments pain reduction of other topically applied analgesics in the treatment of trigeminal neuralgia

J Clin Anesth. 2017 May:38:154-155. doi: 10.1016/j.jclinane.2017.01.040. Epub 2017 Feb 17.

Authors

David J Kopsky¹, Jan M Keppel Hesselink²

Affiliations

¹ Clinical Operations of the Institute of Neuropathic Pain, Amsterdam, The Netherlands. Electronic address: info@neuropathie.nu.
² Research & Development of the Institute of Neuropathic Pain, Bosch en Duin, The Netherlands.

PMID: 28372657
DOI: 10.1016/j.jclinane.2017.01.040

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Cutaneous
Aged
Analgesics / pharmacology*
Baclofen / pharmacology
Drug Synergism
Humans
Hyperalgesia / drug therapy*
Hyperalgesia / etiology
Ketamine / pharmacology
Male
Middle Aged
Nociceptors / drug effects
Pain Management / methods*
Phenytoin / pharmacology*
Skin Cream / pharmacology
Time Factors
Touch
Trigeminal Neuralgia / complications
Trigeminal Neuralgia / drug therapy*

Substances

Analgesics
Phenytoin
Ketamine
Baclofen